drugset / Trial / NCT02516904
A Single Ascending Dose Study of CD101 IV in Healthy Subjects
RandomizedSingle-groupQuadruple-blindTreatment
Summary
A single ascending dose study to evaluate the safety, tolerability, and pharmacokinetics of CD101 IV
Timeline
- Start
- 2015-07
- Primary completion
- 2015-10
- Completion
- 2015-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rezafungin | Other / unclassified | — | Intravenous |
Indications
No indication recorded.